Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Retained Earnings (2019 - 2025)

Bioadaptives' Retained Earnings history spans 7 years, with the latest figure at -$9.9 million for Q3 2025.

  • For Q3 2025, Retained Earnings fell 12.58% year-over-year to -$9.9 million; the TTM value through Sep 2025 reached -$9.9 million, down 12.58%, while the annual FY2024 figure was -$9.2 million, 10.88% down from the prior year.
  • Retained Earnings for Q3 2025 was -$9.9 million at Bioadaptives, down from -$9.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$6.1 million in Q1 2021 and bottomed at -$9.9 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$8.0 million (2023), against an average of -$8.0 million.
  • The largest annual shift saw Retained Earnings decreased 22.04% in 2021 before it fell 6.28% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$6.7 million in 2021, then fell by 13.45% to -$7.6 million in 2022, then decreased by 9.43% to -$8.3 million in 2023, then dropped by 10.88% to -$9.2 million in 2024, then fell by 8.02% to -$9.9 million in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Retained Earnings are -$9.9 million (Q3 2025), -$9.5 million (Q2 2025), and -$9.4 million (Q1 2025).